Incyte Announces Positive Top-Line Results from Phase III Study of Ruxolitinib in Patients with Polycythemia Vera
SQM Reports Earnings For Fourth Quarter 2013
Global Outsourcing 100® Designates Top Outsourcing Partners
The U.S. economy is in decent shape, but we are being even more selective given recent outperformance.
As macro headwinds mount, we would look for a larger valuation discount among consumer cyclical names.
As the risk of increasing inflation looms, the risk/reward opportunity in stocks does not signal a screaming buy to us at this point.